Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
30 Cards in this Set
- Front
- Back
types of hypertension
|
primary hypertension: no known cause, 92%, 90% 55+ age
secondary: known cause, include: kidney disease hyperthyroidism pregnancy erythropoietin pheochromacytoma sleep apnea contraceptive use |
|
how to measure blood pressure
|
blood pressure=cardiac output x peripheral resistance
|
|
baroreceptor
|
sens BP at aortic arch and carotid sinus, sympathetic pathway, instantly
|
|
RAAS
|
protein hormones in kidney, take hours
angiotensinogn->antiotensin 1->2->ADH and aldosterone -cause vasoconstriction and renal retention of sodium/water vasoconstriction increase BP retention of water increase blood volume/increase cardiac output |
|
renin
|
catalyze formation of angiotensionogen to angiotensin I
-made by juxtaglomerular function: |
|
Angiotensin converting enzymes (ACE)
|
convert angio I->II
angio II: produce vasoconstriction in posterior pituitary releasing ADH, causing water retention under hypotention, kidney retains water |
|
obese and sodium impact and potassium
|
obesity increase insulin secretion, cause reabsorption of NA and water, having higher blood volume
high NA cause reabsorption of blood potassium is negative |
|
DASH
|
dietary approaches to stop hypertension
best to do in prehypertension |
|
Diuretics 3 classes
|
loop diuretics
thiazide diuretics potassium sparing diuretics/aldosterone antagonists |
|
function of diuretics
|
block Na and Cl reabsorption from nephron, making tubule attracts water prevent reabsorption.
retention of water promote excretion of water and sodium/chloride ions |
|
Loop diuretics
|
block NACL reabsorption in ascending loop
cause hypokalemia (K+), due to transportion of K+ into blood |
|
Thiazide Diuretics
|
block at distal tube NACL
decrease vascular resistance less effective than loop diuretics |
|
Potassum sparing diuretics/aldosterone antagonist
|
minimal among 3, block aldosterone receptor in collecting duct.
aldesterone cause NA reuptake and K secretion, blocking cause NA excretion and K retention, (potassium sparing) this is used to counter hypokalemia side effect, can cause hyperkalemia tho |
|
beta blocker treat hypertension by 2 mechanisms
|
1. block cardiac beta 1 receptor
2. block beta 1 receptor on juxtaglomerular cells |
|
blocking cardiac beta 1 receptor
|
binding catecholamines (Epi or NoEpi) to beta receptor = increase cardiac output, block beta receptor=decrease cardiac output
|
|
blocking beta 1 receptor on jux cells
|
jux=release renin=activate RAAS=vasoconstriction
-beta blocker decrease renin, decrease RAAS and decrease peripheral resistance |
|
suffix for beta blocker
|
olol
eg propanolo |
|
type of beta blockers
|
antagonists, since they block receptors
|
|
first gen vs 2nd gen in beta blockers
|
1st gen: nonselective, block both beta 1 and beta 2(in lung)
2nd gen: only block beta 1 |
|
ACEI
|
1. -decrease angiotensin II production (II = vasoconstrictor)
-also decrease total blood volume, reduce both cardiac output and peripheral resistance 2. inhibit breakdown of bradykinin (this cause vasodilation) or making more bradykinin |
|
suffix for ACEI
|
pril.
captopril ramipril. |
|
angiotensin receptor blockers ARBs
|
similar to ACEI, decrease angiotensin II.
block binding of angio II to receptor AT1. DONOT affect synthesis vasodilation. also cause decrease aldosterone=increase sodium and water excretion. |
|
suffix for ARBs
|
sartan
losartan valsartan |
|
direct renin inhibitors DRIs
|
bind renin and block conversion from angiotensinogen to angiotensin I.
cause hyperkalemia |
|
calcium channel blockers
|
Ca channel is essential for contraction
blocker decrease contraction. |
|
2 categories of calcium channel blockers
|
1. dihydropyridine calcium channel blockers
2. non-dihydropyridine calcium channel blockers |
|
dihydropyridine calcium channel blockers
|
block calcium influx in SM, cause relaxation and vasodilation.
DO NOT act on the heart, |
|
suffix for dihydropyridine calcium channel blockers
|
dipine
nifedipine felodipine |
|
non-dihydropyridine calcium channel blockers
|
block heart and SM in arteries.
vasodilation and decrease cardiac output |
|
centrally acting alpha 2 agonist
|
activate alpha 2 receptor in brainstem
-decrease sympathetic outflow to heart and BV. -activation of alpha 2 receptor=inhibition of sympathetic=decrease cardiac output and peripheral resistance |